China National Accord Medicines Ltd. Goodwill

China National Accord Medicines Ltd. posts a goodwill of $1.6B as of September 2026. That compares with $1.9B in the prior-year period — down 13.7% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, China National Accord Medicines Ltd.'s goodwill was $1.9B. The latest reading is $1.6B — a 13.7% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

Goodwill is one piece of China National Accord Medicines Ltd.'s financial statement story. At $1.6B, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for 000028.SZ's goodwill usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; China National Accord Medicines Ltd.'s other metric pages and overview cover the third.